Tech Company Financing Transactions

SimBioSys Funding Round

SimBioSys secured a $15 million Series A funding round on 10/28/2021. Investors included Genoa Ventures, Northpond Ventures and AV8 Ventures.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series A

Genoa Ventures (Lead Investor) (Vikram Chaudhery)

Northpond Ventures (Lead Investor) (Andrea Jackson)

AV8 Ventures

Heritage Medical Systems

Mayo Medical Ventures

Proceeds Purpose
The new funding will allow SimBioSys to expand its state-of-the-art technology into other solid tumors beyond its current focus on breast cancer.

Company Information

Company Status
Private & Independent
Healthcare IT
Mailing Address
180 N LaSalle St. 3250
Chicago, IL 60601
Email Address
SimBioSys is a software company deploying a combination of biophysical modeling and artificial intelligence to revolutionize precision cancer care. Our portfolio of software applications enables individualized treatment planning, accelerated drug development, clinical trial optimization and comprehensive biomarker development.
SimBioSys LinkedIn Company Profile
Social Media
SimBioSys Company Twitter Account
Company News
SimBioSys News
SimBioSys on Facebook
SimBioSys on YouTube

Management Team

Email & Social
Chief Executive Officer
Tushar Pandey
  Tushar Pandey LinkedIn Profile  Tushar Pandey Twitter Account  Tushar Pandey News  Tushar Pandey on Facebook
Chief Medical Officer
Anu Antony
  Anu Antony LinkedIn Profile  Anu Antony Twitter Account  Anu Antony News  Anu Antony on Facebook
Chief Scientific Officer
John Cole
  John Cole LinkedIn Profile  John Cole Twitter Account  John Cole News  John Cole on Facebook
Chief Technical Officer
Joseph Peterson
  Joseph Peterson LinkedIn Profile  Joseph Peterson Twitter Account  Joseph Peterson News  Joseph Peterson on Facebook
Vice President
Tricia Carrigan
  Tricia Carrigan LinkedIn Profile  Tricia Carrigan Twitter Account  Tricia Carrigan News  Tricia Carrigan on Facebook
VP - Bus. Development
Timothy Foley
  Timothy Foley LinkedIn Profile  Timothy Foley Twitter Account  Timothy Foley News  Timothy Foley on Facebook
VP - Regulatory Affairs
Eduardo Braun
  Eduardo Braun LinkedIn Profile  Eduardo Braun Twitter Account  Eduardo Braun News  Eduardo Braun on Facebook



Browse more venture capital transactions:

Prev: 10/28/2021: Immunefi venture capital transaction
Next: 10/28/2021: Selfbook venture capital transaction


Share this article


Where The Data Comes From

We do our best to record all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary